Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2025 Aug 4;15(1):28346.
doi: 10.1038/s41598-025-13673-1.

Prevalence and patterns of antiretroviral resistance in HIV-infected Latin American asylum seekers

Affiliations

Prevalence and patterns of antiretroviral resistance in HIV-infected Latin American asylum seekers

Samuel Manzano et al. Sci Rep. .

Abstract

The recent increase in Latin American asylum seekers in Spain has been accompanied by a rise in HIV diagnoses. However, their clinical profile, particularly regarding antiretroviral resistance, is poorly characterized. We aimed to assess the prevalence of resistance-associated mutations and their impact on treatment management in this vulnerable population. We conducted a prospective cohort study (2022-2023) with six-month follow-up, enrolling Latin American asylum seekers living with HIV, attending their first HIV consultation in Spain. Individuals with a viral load > 1,000 copies/mL, regardless of prior ART exposure, underwent genotypic resistance testing. Mutations were identified using the WHO Surveillance Drug Resistance Mutations (SDRM) list, and resistance was interpreted via the Stanford HIV Drug Resistance Database algorithm. Of 653 participants, 153 met inclusion criteria, and 141 (21.6%) had valid resistance results. Overall, 22.7% harbored SDRMs to NNRTIs, NRTIs, or PIs (15.0% ART-naïve vs. 32.8% ART-experienced). NNRTI mutations were most frequent (21.3%), particularly in ART-experienced individuals (31.1%). NRTI mutations were present in 7.1% overall (13.1% ART-experienced). The most common mutations were K103N/S (19.1%), P225H (5.0%), and M184V (4.3%). Among ART-experienced individuals, resistance to efavirenz, nevirapine, and rilpivirine was 31.1%, 32.7%, and 19.7%, respectively; 11.4% showed lamivudine resistance. Notably, 82.3% of ART-experienced participants reported barriers to healthcare access, with a 90% rate of treatment discontinuation. In this cohort of Latin American asylum seekers, resistance to NNRTIs was alarmingly high, especially among those with prior ART exposure and interrupted treatment. These findings underscore the need for optimized treatment strategies and improved healthcare access for migrant populations with HIV.

Keywords: Asylum seekers; HIV; Latin american; Migrants; Mutations; Resistance.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests. Ethical approval and consent to participate: This study complied with the Declaration of Helsinki and adhered to the STROBE guidelines for reporting observational studies (see Supplementary Material). The study protocol was approved by the Infanta Leonor Hospital Research Ethics Board in 2022 and was registered at ClinicalTrials.gov (NCT05998499). Informed consent was obtained from all participants prior to inclusion.

Figures

Fig. 1
Fig. 1
Flowchart of individuals included in the study.
Fig. 2
Fig. 2
Percentage of Resistance to NRTIs drugs Expressed by Type of Antiretroviral Treatment and Corresponding Subgroup (n = 141). ABC, abacavir; AZT, zidovudine; 3TC, lamivudine; FTC, emtricitabine; TDF, tenofovir disoproxil fumarate.
Fig. 3
Fig. 3
Percentage of Resistance to NNRTIs drugs Expressed by Type of Antiretroviral Treatment and Corresponding Subgroup (n = 141).
Fig. 4
Fig. 4
Most Frequent SDRM for NNRTIs in Previously Treated and Naive Patients (n = 141).
Fig. 5
Fig. 5
Most Frequent SDRM for NRTIs in Previously Treated and Naive Patients (n = 141).

Similar articles

References

    1. Hoja informativa —. Últimas estadísticas sobre el estado de la epidemia de sida [Internet]. [citado 16 de septiembre de 2024]. Disponible en: https://www.unaids.org/es/resources/fact-sheet
    1. By-Nc-Sa, C. Unidad de vigilancia de VIH, ITS y hepatitis. Vigilancia Epidemiológica del VIH y sida en España. : Sistema de Información sobre Nuevos Diagnósticos de VIH y Registro Nacional de Casos de Sida. Centro Nacional de Epidemiología. Instituto de Salud Carlos III/ División de control de VIH, ITS, Hepatitis virales y tuberculosis. Ministerio de Sanidad. Madrid; noviembre 2024. (2023).
    1. European Commission. Eurostat. Migration and asylum in Europe [Internet]. LU: Publications Office; 2023 [citado 18 de septiembre de 2024]. (Migration and asylum in Europe …Disponible en: https://data.europa.eu/doi/10.2785/353399.
    1. INE [Internet]. INEbase / Demografía y población /Fenómenos demográficos /Estadística de Migraciones y Cambios de Residencia / Últimos datos (&cid=1254736177098&menu=ultiDatos&idp=1254735573002, ).
    1. Abubakar, I. et al. The UCL–Lancet commission on migration and health: the health of a world on the move. Lancet Lond. Engl. 15 De Diciembre De. 392 (10164), 2606–2654 (2018). - PMC - PubMed

Substances